Researchers working on Covid vaccine that people can drink
Darpan News Desk IANS, 23 Jan, 2023 01:58 PM
San Francisco, Jan 23 (IANS) Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as "swish and swallow" oral vaccines.
The vaccine, called QYNDR, completed its phase 1 clinical trial and is currently waiting on more funding to conduct the more detailed, advanced trials that could actually bring the vaccine to market, reports CNET.
"The QYNDR vaccine is pronounced 'kinder', because it's a softer way to deliver a vaccine," Kyle Flanigan, founder of QYNDR's maker, US Specialty Formulations, was quoted as saying.
Moreover, the report said that promising clinical trial results from New Zealand offer hope that QYNDR will be a viable option for protection against the string of Covid-19 variants circulating now.
"It's really challenging to have a vaccine survive making it through your digestive system," Flanigan said.
"We were able to figure out how to get a vaccine past the stomach and into the gut and have it be effective and induce the appropriate response," she added.
Scientists are hopeful that mucosal vaccines will not only protect against severe diseases and death, as revolutionary mRNA vaccines and boosters have but also ward off infections, the report said.
Different from traditional vaccines, mucosal vaccines enter through our mucous membranes, either through our nose (as in the much-discussed nasal Covid-19 vaccine) or through our gut (as in the orally suspended QYNDRs).
Mucosal vaccines have been supported as viable, or even preferable, options for combating Covid-19 infections due to the different types of immunity they produce and the fact that it begins right where the virus enters our bodies, the report mentioned.
A high-energy breakfast and modest dinner can control dangerous blood sugar spikes all day, says a study. More than 382 million people in the world suffer from diabetes, predominantly type-2 diabetes.
A team of Indian-American researchers has found that not just what you eat but when you do so is equally important in order to protect your heart from early ageing.
Public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support, a tobacco-free world could be possible in less than three decades.
WASHINGTON — Ebola's toll moved beyond 10,000 deaths Thursday even as researchers warned of yet another threat to hard-hit West Africa: On the heels of the unprecedented devastation, large outbreaks of measles and other vaccine-preventable diseases could move into the region.
The makers of the nasal spray version of the flu vaccine say now they know why it has failed to protect young U.S. children against swine flu — fragile doses got too warm.
Researchers led by an Indian-origin scientist have developed a new drug that may serve as a treatment against multi-drug resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies.
